U.S. Court Of Appeals For The Federal Circuit Affirms Prior Delaware District Court Rulings In Favor Of Acadia In Nuplazid® (Pimavanserin) Composition Of Matter Patent
ACADIA Pharmaceuticals Inc ACAD.O:
U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT AFFIRMS PRIOR DELAWARE DISTRICT COURT RULINGS IN FAVOR OF ACADIA IN NUPLAZID® (PIMAVANSERIN) COMPOSITION OF MATTER PATENT
ACADIA PHARMACEUTICALS INC - NUPLAZID PATENT PROTECTION EXTENDED TO 2030
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.